Consequences of cerebral small vessel disease: Disability, mortality, and prognosis

Cerebral Small Vessel Disease

Volumn , Issue , 2011, Pages 273-282

  Poggesi, Anna ^a   Pantoni, Leonardo ^b   Inzitari, Domenico ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84923442211     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9781139382694.023     Document Type: Chapter

References (51)

1. World Health Organization. International Classification of Impairments, Disabilities and Handicaps. Geneva: World Health Organization; 1980.
2. World Health Organization. International Classification of Functioning, Disability and Health. Geneva: World Health Organization; 2001. Available from: http://www3.who.int/icf/intros/ICF-Eng-Intro.pdf (accessed January 3, 2014).
3. Katz S. Assessing selfmaintenance: Activities of Daily Living, mobility, and Instrumental Activities of Daily Living. J Am GeriatrSoc 1983; 31:721-727.
4. Lawton MP, Brody EM. Assessment of older people: self-maintaining and Instrumental Activities of Daily Living. Gerontologist 1969; 9:179-186.
5. Gelinas I, Gauthier L, McIntyre M, et al. Development of a functional measure for persons with Alzheimer’s disease: the Disability Assessment for Dementia. Am J Occup Ther 1999; 53:471-481.
6. Van Swieten J, Koudstaal P, Visser M, et al. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988; 19:604-607.
7. Mahoney FI, Barthel DW. Functional evaluation: the Barthel Index. MD State Med J 1965; 14:61-65.
8. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. AJR Am J Roentgenol 1987; 149:351-356.
9. Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol 2010; 9:689-701.
10. Pantoni L, Garcia JH. The significance of cerebral white matter abnormalities 100 years after Binswanger’s report. A review. Stroke 1995; 26:1293-1301.
11. Tarvonen-Schroder S, Kurki T, Raiha I, Sourander L. Leukoaraiosis and cause of death: a five year follow up. J Neurol Neurosurg Psychiatry 1995; 58:586-589.
12. Inzitari D, Di Carlo A, Mascalchi M, Pracucci G, Amaducci L. The cardiovascular outcome of patients with motor impairment and extensive leukoaraiosis. Arch Neurol 1995; 52:687-691.
13. Inzitari D, Cadelo M, Marranci ML, Pracucci G, Pantoni L. Vascular deaths in elderly neurological patients with leukoaraiosis. J Neurol Neurosurg Psychiatry 1997; 62:177-181.
14. Briley DP, Haroon S, Sergent SM, Thomas S. Does leukoaraiosis predict morbidity and mortality? Neurology 2000; 54:90-94.
15. Inzitari D. Leukoaraiosis: an independent risk factor for stroke? Stroke 2003; 34:2067-2071.
16. Pantoni L. Leukoaraiosis: from an ancient term to an actual markerof poor prognosis. Stroke 2008; 39:1401-1403.
17. Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and metaanalysis. BMJ 2010; 341:3666.
18. Erkinjuntti T, Pantoni L, Scheltens P. Cooperation and networking on white matter disorders: the European Task Force on Age-Related White Matter Changes. Dement Geriatr Cogn Disord 1998; 9(Suppl 1): 44-45.
19. Pantoni L, Basile AM, Pracucci G, et al. Impact of age-related cerebral white matter changes on the transition to disability-the LADIS study: rationale, design and methodology. Neuroepidemiology 2005; 24:51-62.
20. The LADIS Study Group. 2001-2011: a decade of the LADIS (Leukoaraiosis And DISability) study: what have we learned about white matter changes and small-vessel disease? Cerebrovasc Dis 2011; 32:577-588.
21. Pantoni L, Poggesi A, Basile AM, et al. LADIS Study Group. Leukoaraiosis predicts hidden global functioning impairment in nondisabled older people: the LADIS (Leukoaraiosis And DISability in the elderly) study. J Am Geriatr Soc 2006; 54:1095-2101.
22. Inzitari D, Simoni M, Pracucci G, et al. LADIS Study Group. Risk of rapid global functional decline in elderly patients with severe cerebral age-related white matter changes: the LADIS study. Arch Intern Med 2007; 167:81-88.
23. Inzitari D, Pracucci G, Poggesi A, et al. LADIS Study Group. Changes in white matter as determinant of global functional decline in older independent outpatients: three year follow-up of LADIS (Leukoaraiosis And DISability) study cohort. BMJ 2009; 339:2477.
24. Norrving B. Long-term prognosis after lacunar infarction. Lancet Neurol 2003; 2:238-245.
25. Fisher CM. Lacunar stroke and infarcts: a review. Neurology 1982; 32:871-876.
26. Sacco S, Marini C, Totaro R, et al. A population-based study of the incidence and prognosis of lacunar stroke. Neurology 2006; 66:1335-1338.
27. Bejot Y, Catteau A, Caillier M, et al. Trends in incidence, risk factors, and survival in symptomatic lacunar stroke in Dijon, France, from 1989 to 2006: a population-based study. Stroke 2008; 39:1945-1951.
28. Staaf G, Lindgren A, Norrving B. Pure motor stroke from presumed lacunar infarct: long-term prognosis for survival and risk of recurrent stroke. Stroke 2001; 32:2592-2596.
29. Eriksson S-E, Olsson JE. Survival and recurrent strokes in patients with different subtypes of stroke: a 14-year follow-up study. Cerebrovasc Dis 2001; 12: 171-180.
30. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991; 337:1521-1526.
31. Samuelsson M, Soderfelt B, Olsson GB. Functional outcome in patients withlacunar infarction. Stroke 1996; 27:842-846.
32. De Jong G, Kessels F, Lodder J. Two types of lacunar infarcts. Further arguments from a study on prognosis. Stroke 2002; 33:2072-2076.
33. Vermeer S, Longstreth WT Jr, Koudstaal PJ. Silent brain infarcts: a systematic review. Lancet Neurology 2007; 6:611-619.
34. Miyao S, Takano A, Teramoto J, Takahashi A. Leukoaraiosis in relation to prognosis for patients with lacunar infarction. Stroke 1992; 23:1434-1438.
35. Yamamoto Y, Akiguchi I, Oiwa K, et al. Twenty-four-hour blood pressure and MRI as predictive factors for different outcomes in patients with lacunar infarct. Stroke 2002; 33:297-305.
36. Koga H, Takashima Y, Murakawa R, et al. Cognitive consequences of multiple lacunes and leukoaraiosis as vascular cognitive impairment in community-dwelling elderly individuals. J Stroke Cerebrovasc Dis 2009; 18:32-37.
37. Benisty S, Gouw AA, Porcher R, et al. Location of lacunar infarcts correlates with cognition in a sample of non disabled subjects with age-related white matter changes: the LADIS study. J Neurol Neurosurg Psychiatry 2009; 80:478-483.
38. Jacova C, Pearce LA, Costello R, et al. Cognitive impairment in lacunar strokes: the SPS3 trial. Ann Neurol 2012; 72:351-362.
39. Van der Flier WM, Cordonnier C. Microbleeds in vascular dementia: clinical aspects. Exp Gerontol 2012; 47:853-857.
40. Cordonnier C, van der Flier WM. Brain microbleeds and Alzheimer’s disease: innocent observation or key player? Brain 2011; 134:335-344.
41. Cordonnier C, Al-Shahi SR, Wardlaw J. Spontaneous brain microbleeds: systematicreview, subgroup analyses and standards for study design and reporting. Brain 2007; 130: 1988-2003.
42. Biessels GJ, Zwanenburg JJ, Visser F, Frijns CJ, Luijten PR. Hypertensive cerebral hemorrhage: imaging the leak with 7-T MRI. Neurology 2010; 75:572-573.
43. Theysohn JM, Kraff O, Maderwald S, et al. Seven Tesla MRI of microbleeds and white matter lesions as seen in vascular dementia. J Magn Reson Imaging 2011; 33:782-791.
44. Lesnik Oberstein SA, van den Boom R, van Buchem MA, et al. Cerebral microbleeds in CADASIL. Neurology 2001; 57:1066-1070.
45. Viswanathan A, Guichard JP, Gschwendtner A, et al. Blood pressure and haemoglobin A1c are associated with microhaemorrhage in CADASIL: a two-centre cohort study. Brain 2006; 129:2375-2383.
46. Viswanathan A, Gschwendtner A, Guichard JP, et al. Lacunar lesions are independently associated with disability and cognitive impairment in CADASIL. Neurology 2007; 69:172-179.
47. Henneman WJ, Sluimer JD, Cordonnier C, et al. MRI biomarkers of vascular damage and atrophy predicting mortality in a memory clinic population. Stroke 2009; 40:492-498.
48. Altmann-Schneider I, Trompet S, de Craen AJ, et al. Cerebral microbleeds are predictive of mortality in the elderly. Stroke 2011; 42:638-644.
49. Dufouil C, Chalmers J, Coskun O, et al. Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection aGainst Recurrent Stroke Study)Magnetic Resonance Imaging Substudy. Circulation 2005; 112:1644-1650.
50. Mok VC, Lam WW, Fan YH, et al. Effects of statins on the progression of cerebral white matter lesion: post hoc analysis of the ROCAS (Regression of Cerebral Artery Stenosis) study. J Neurol 2009; 256:750-757.
51. Ten Dam VH, van den Heuvel DM, van Buchem MA, et al. of pravastatin on cerebral infarcts and white matter lesions. Neurology 2005; 64:1807-1809.